08:00 , Dec 5, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Dyslipidemia; metabolic disease Patatin-like phospholipase domain containing 2 (PNPLA2; ATGL) In vitro and mouse studies have identified an inhibitor of ATGL that might help...
07:00 , Jun 23, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine disease Cachexia Patatin-like phospholipase domain containing 2 (PNPLA2; ATGL) Mouse and human studies suggest inhibiting ATGL could help treat cancer cachexia. In two mouse models...